MADINA JUCABAN: Open Payments
NPI 1417553116 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 43 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $275 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $267 |
| Lundbeck LLC | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| ACADIA Pharmaceuticals Inc | 2 | $59 |
| TG Therapeutics, Inc. | 2 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| UCB, Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $51 |
| ARGENX US, INC. | 2 | $39 |
Products named: QULIPTA, UBRELVY, VYEPTI, AUSTEDO XR, KESIMPTA, NUPLAZID, REXULTI, BRIUMVI.
Industry payments across SC — which companies pay providers there.
